Bookshelf

NOTE: Results for 2009 are not included because composite measures were used that year rather than individual measures. AM-1 = heart attack patients given aspirin at arrival; AM-2 = heart attack patients given aspirin at discharge; AM-5 = heart attack patients given beta blocker at discharge; AM-6 = heart attack patients given beta blocker at arrival; AM-10 = statin prescribed at discharge.
SOURCE: Lovell FHCC.

Persistence of beta-blocker use in the second six months of hospitalization for a heart attack ranged from 63% to 91%. No region maintained a level of treatment persistence above 92% in the second six months. Maps 2 and 3 use a fixed scale comprising equal ranges to demonstrate both the initiation and persistence of treatment.

The figure shows the percentage of Part D beneficiaries in each patient cohort receiving indicated medications. For heart attack patients, medication use was measured 7-12 months following discharge from the hospital after a heart attack in 2008 or 2009 in order to assess whether therapy continued beyond the immediate period after discharge. Effective care for diabetics was measured for 2010 in patients age 65 to 75.

Adherence to recommendations for the initiation of beta-blocker therapy in the first six months following a heart attack ranged from about 60% to more than 92% across hospital referral regions. Maps 2 and 3 use a fixed scale comprising equal ranges to demonstrate both the initiation and persistence of treatment.

NOTES: Heart disease is based on self-reported responses to questions about whether respondents had ever been told by a doctor or other health professional that they had coronary heart disease, angina (angina pectoris), a heart attack (myocardial infarction), or any other kind of heart disease or heart condition. Cancer is based on self-reported responses to a question about whether respondents had ever been told by a doctor or other health professional that they had cancer or a malignancy of any kind (excluding squamous cell and basal cell carcinomas). See data table for Figure 12.

NOTES: Heart disease is based on self-reported responses to questions about whether respondents had ever been told by a doctor or other health professional that they had coronary heart disease, angina (angina pectoris), a heart attack (myocardial infarction), or any other kind of heart disease or heart condition. Cancer is based on self-reported responses to a question about whether respondents had ever been told by a doctor or other health professional that they had cancer or a malignancy of any kind. Excludes squamous cell and basal cell carcinoma. See data table for Figure 9.
SOURCE: NCHS, National Health Interview Survey (NHIS).

Click here for spreadsheet version Click here for Powerpoint
NOTES: Conditions are respondent-reported as ever being told by a doctor or other health professional. Serious heart disease includes heart attack, coronary heart disease, or angina. Hypertension is told on at least two occasions. See data table for Figure 10.
SOURCE: CDC/NCHS, National Health Interview Survey.

Obesity is defined as body mass index ≥30 kg/m². Diabetes is defined as self-report and/or A1c ≥6.5% and/or FPG ≥126 mg/dL. Heart disease is self-reported and includes heart attack or heart failure. Estimates are age-standardized to the National Health Interview Survey 2010 total population using age categories 18–44, 45–64, and ≥65 years. Conversions for A1c and glucose values are provided in Diabetes in America Appendix 1 Conversions. A1c, glycosylated hemoglobin; FPG, fasting plasma glucose.

Obesity is defined as body mass index ≥30 kg/m². Diabetes is defined as self-report and/or A1c ≥6.5% and/or FPG ≥126 mg/dL. Heart disease is self-reported and includes heart attack or heart failure. Estimates are age-standardized to the National Health Interview Survey 2010 total population using age categories 18–44, 45–64, and ≥65 years. Conversions for A1c and glucose values are provided in Diabetes in America Appendix 1 Conversions. A1c, glycosylated hemoglobin; FPG, fasting plasma glucose.

ED = emergency department; MI = myocardial infarction; TIA = transient ischemic attack

SOURCE: Committee analysis of unpublished Dartmouth data.

Trends in the Age-Standardized Prevalence of Diabetes and Heart Disease Among Adult Men Age ≥20 Years, U.S., 1976–2020 Q1.
Diabetes is defined as self-reported or self-report and/or A1c (≥6.5%) and/or FPG (≥126 mg/dL); diabetes is self-reported when combined with heart disease. Heart disease is self-reported and includes heart attack or heart failure. Estimates are standardized to the National Health Interview Survey 2019 total population, using age categories 18–44, 45–64, and ≥65 years. Conversion formulas for A1c and glucose values are provided in the Conversions section. A1c, glycosylated hemoglobin; FPG, fasting plasma glucose.
SOURCE: National Health and Nutrition Examination Surveys (NHANES) II (1976–1980), III (1988–1994), and 1999–2020 Q1

Trends in the Age-Standardized Prevalence of Diabetes and Heart Disease Among Adult Women Age ≥20 Years, U.S., 1976–2020 Q1.
Diabetes is defined as self-reported or self-report and/or A1c (≥6.5%) and/or FPG (≥126 mg/dL); diabetes is self-reported when combined with heart disease. Heart disease is self-reported and includes heart attack or heart failure. Estimates are standardized to the National Health Interview Survey 2019 total population, using age categories 18–44, 45–64, and ≥65 years. Conversion formulas for A1c and glucose values are provided in the Conversions section. A1c, glycosylated hemoglobin; FPG, fasting plasma glucose.
SOURCE: National Health and Nutrition Examination Surveys (NHANES) II (1976–1980), III (1988–1994), and 1999–2020 Q1

Myocardial Infarction (Heart Attack) Warning Signs in Women. U.S. Department of Health and Human Services Office on Women's Health

Myocardial Infarction (Heart Attack) Warning Signs in Women. U.S. Department of Health and Human Services Office on Women's Health